# Universal Health Services Inc: overview

UHS · NYSE · CIK 352915 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uhs.md) · [Financials](/companies/uhs/financials.md) · [Filings](/companies/uhs/filings.md) · [Insiders](/companies/uhs/insiders.md)

Latest reported revenue: [$4.64bn](/filings/0001193125-26-340278.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-340278).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,963](/filings/0001193125-25-272385.md) | [4,114 d](/filings/0001193125-26-071676.md) | [4,100](/filings/0001193125-26-211992.md) | [4,284](/filings/0001193125-26-340278.md) | [4,495](/filings/0001193125-25-272385.md) | [4,486 d](/filings/0001193125-26-071676.md) | [4,495](/filings/0001193125-26-211992.md) | [4,638](/filings/0001193125-26-340278.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [9.7%](/filings/0001193125-25-272385.md) | [11.5% d](/filings/0001193125-26-071676.md) | [11.1%](/filings/0001193125-26-211992.md) | [11.7%](/filings/0001193125-26-340278.md) | [11.6%](/filings/0001193125-25-272385.md) | [11.5% d](/filings/0001193125-26-071676.md) | [11.2%](/filings/0001193125-26-211992.md) | [11.1%](/filings/0001193125-26-340278.md) |
| Net margin | % | [6.5%](/filings/0001193125-25-272385.md) | [8.1% d](/filings/0001193125-26-071676.md) | [7.7%](/filings/0001193125-26-211992.md) | [8.2%](/filings/0001193125-26-340278.md) | [8.3%](/filings/0001193125-25-272385.md) | [9.9% d](/filings/0001193125-26-071676.md) | [7.8%](/filings/0001193125-26-211992.md) | [7.7%](/filings/0001193125-26-340278.md) |
| Diluted EPS | $ per share | [3.80](/filings/0001193125-25-272385.md) | not reported | [4.80](/filings/0001193125-26-211992.md) | [5.43](/filings/0001193125-26-340278.md) | [5.86](/filings/0001193125-25-272385.md) | not reported | [5.65](/filings/0001193125-26-211992.md) | [5.98](/filings/0001193125-26-340278.md) |
| Free cash flow | $m | [85.0 d](/filings/0001193125-25-272385.md) | [412 d](/filings/0001193125-26-071676.md) | [121](/filings/0001193125-26-211992.md) | [283 d](/filings/0001193125-26-340278.md) | [152 d](/filings/0001193125-25-272385.md) | [293 d](/filings/0001193125-26-071676.md) | [184](/filings/0001193125-26-211992.md) | [216 d](/filings/0001193125-26-340278.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.6](/filings/0000950170-24-021175.md) | [13.4](/filings/0000950170-25-027785.md) | [14.3](/filings/0001193125-26-071676.md) | [15.8](/filings/0001193125-26-071676.md) | [17.4](/filings/0001193125-26-071676.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [10.8%](/filings/0000950170-24-021175.md) | [7.5%](/filings/0000950170-25-027785.md) | [8.2%](/filings/0001193125-26-071676.md) | [10.6%](/filings/0001193125-26-071676.md) | [11.5%](/filings/0001193125-26-071676.md) |
| Net margin | % | [7.8%](/filings/0000950170-24-021175.md) | [5.0%](/filings/0000950170-25-027785.md) | [5.0%](/filings/0001193125-26-071676.md) | [7.2%](/filings/0001193125-26-071676.md) | [8.6%](/filings/0001193125-26-071676.md) |
| Diluted EPS | $ per share | [11.82](/filings/0000950170-24-021175.md) | [9.14](/filings/0000950170-25-027785.md) | [10.23](/filings/0001193125-26-071676.md) | [16.82](/filings/0001193125-26-071676.md) | [23.10](/filings/0001193125-26-071676.md) |
| Free cash flow | $bn | [0.0](/filings/0000950170-24-021175.md) | [0.3](/filings/0000950170-25-027785.md) | [0.5](/filings/0001193125-26-071676.md) | [1.1](/filings/0001193125-26-071676.md) | [0.8](/filings/0001193125-26-071676.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/uhs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $677.2m | 4,554,670 |  | Added +130,389 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $677.2m | 4,554,670 |  | Added +130,389 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $603.7m | 4,059,826 |  | Reduced −285,257 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $504.4m | 3,392,199 |  | Reduced −60,686 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $364.6m | 2,452,177 |  | Reduced −55,990 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $328.7m | 2,210,595 |  | Added +429,333 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $312.6m | 2,102,613 |  | Reduced −476,776 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $293.2m | 1,974,065 |  | Added +26,197 |
| [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $292.8m | 1,969,327 |  | Added +57,092 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $290.1m | 1,951,147 |  | Added +362,027 |

## Recent filings

[All 1,131 filings](/companies/uhs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 17:03 ET | [8-K](/filings/0001193125-26-434414.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-434414 |
| 2026-08-21 | 07:58 ET | [8-K](/filings/0001193125-26-359953.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-359953 |
| 2026-08-17 | 16:15 ET | [8-K](/filings/0001193125-26-354078.md) | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-354078 |
| 2026-08-13 | 09:23 ET | [8-K](/filings/0001193125-26-348057.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-348057 |
| 2026-08-07 | 16:15 ET | [10-Q](/filings/0001193125-26-340278.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340278 |
| 2026-07-28 | 08:19 ET | [8-K](/filings/0001193125-26-318940.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318940 |
| 2026-07-21 | 16:15 ET | [8-K](/filings/0001193125-26-310330.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-310330 |
| 2026-05-22 | 07:30 ET | [8-K](/filings/0001193125-26-235480.md) | 5.07 Shareholder vote results | 0001193125-26-235480 |
| 2026-05-21 | 07:30 ET | [8-K](/filings/0001193125-26-233402.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-233402 |
| 2026-05-07 | 16:17 ET | [10-Q](/filings/0001193125-26-211992.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211992 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-071676.md), filed Feb 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/450123b0-c679-4562-ae0a-37ecd804f740)

## About the filer

- CIK: 352915
- Tickers: UHS
- Exchange: NYSE
- SIC code: 8062 Services-General Medical & Surgical Hospitals, NEC
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:04 ET. No prices; not investment advice.